Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Call for submissions for Innovation and Technology Tariff in England

NHS Innovation Accelerator has initiated process of collection of applications for English innovation funding scheme, the Innovation and Technology Tariff.

The Innovation and Technology Tariff was first introduced in the National Tariff Payment System for 2017/18 in April 2017. It provides add-on reimbursement for device or technology for the period of 3 years. The Tariff is a part of the National Tariff Payment System in England.

In order to qualify for the Tariff, technology should:

  • Address one or more of the following priorities: mental health, urgent and emergency care, primary care
  • Demonstrate, in practice, significant outcomes for significantly lower cost
  • Is supported by an evidence-base and is ready to be diffused across the NHS

Applications can also be performed by manufacturers of medical devices.

For the first year of financing, 6 technologies were selected:

  • Guided mediolateral for episiotomoy to minimise the risk of obstetric and anal sphincter injury
  • Reduction of bacterial contamination and accidental administration of medication
  • Prevention of ventilated associated pneumonia in critically ill patients
  • Web-based applications for the self-management of chronic obstructive pulmonary disease
  • Frozen faecal microbiota transplantation (FMT) for recurrent Clostridium difficile infection
  • Treatment of lower urinary tract symptoms of benign prostatic hyperplasia as a day case (includes placement of Urolift device)

For each technology, a national tariff was established (with exception of placement of Urolift device, for which Health Care Resource Groups were created).

This pathway represents the main system for introduction of innovations into English health care system.

For this year’s call for applications, three priority areas are considered:

  • Mental health
  • Urgent and emergency care
  • Primary care

NHS Innovation Accelerator is accepting applications from 14th of June until 26th of July 2017.

Review conditions and application form here.

Do you need support with developing reimbursement pathway for your technology in England? Learn more about how we can help and contact us for more information.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.